Back
ESC Professional Premium Access

Risk factors and clinical effects of late leaflet thrombosis after transcatheter aortic valve replacement

Session: Thrombosis and anticoagulation in valvular heart disease
Topic: Intervention
Speaker: Doctor M. Bak (Seoul, KR)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Minjung Bak

Samsung Medical Center, Seoul (Korea (Republic of))
0 follower

4 more presentations in this session

To compare efficacy and safety of direct oral anticoagulants in patients with concurrent atrial fibrillation and bioprosthetic heart valve repair or replacement: a systematic review and meta-analysis

Speaker: Doctor A. Kaur (New York City, US)

Access
Abstract
Slides
Thumbnail

Oral anticoagulant treatment in patients with atrial fibrillation early after valvular intervention: a nationwide cohort study

Speaker: Associate Professor C. Christersson (Uppsala, SE)

Access
Abstract
Slides
Thumbnail

Comparing direct oral anticoagulants versus vitamin k antagonist in patients with atrial fibrillation after transcatheter aortic valve replacement: an updated meta-analysis

Speaker: Doctor A. Kaur (New York City, US)

Access
Abstract
Slides
Thumbnail

Hypoattenuated leaflet thickening is associated with silent brain injury

Speaker: Doctor A. Nagy (Budapest, HU)

Access
Abstract
Slides
Thumbnail

Access the full session

Thrombosis and anticoagulation in valvular heart disease

Speakers: Doctor M. Bak, Doctor A. Kaur, Associate Professor C. Christersson, Doctor A. Kaur, Doctor A. Nagy
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb